As concern mounts over spikes in fees charged to credit card users, reports say a mix of low competition and overlapping regulatory action are contributing factors to the problem.
The Australian Securities and Investments Commission has reportedly blamed the problem of overcharged card transactions on the fact that two regulators are responsible for monitoring the problem, leading to cases falling through the cracks. In a filing to the Financial System Inquiry, the Commission reportedly wrote that “a co-regulatory approach to limit an activity appears to have failed because the limitation imposed by payment schemes is not sufficient clear, and is not being enforced by a regulator with sufficient powers and resources to carry out the enforcement,” adding that the body “does not have any direct power to restrict the amount of a surcharge to the reasonable costs incurred by a merchant in accepting a card.”
The ASIC, along with the Australian Competition and Consumer Commissioner, are both given powers to restrict such surcharges, but those powers carry exceptions in certain cases. Now, say reports, merchants are calling upon a single regulator to have the power to monitor the fees.
The Reserve Bank of Australia amended guidelines last year to allow for such a regulator, say reports, but card companies and banks must enforce those rules.
Top card companies Visa and MasterCard, meanwhile, blame such overcharges on a lack of competition in certain industries, like airlines and utilities.
Full Content: Brisbane Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Reserve Greenlights Capital One’s $35.3 Billion Acquisition of Discover
Apr 18, 2025 by
CPI
Google to Appeal Partial Ruling in DOJ Antitrust Case
Apr 18, 2025 by
CPI
Indian Ad Agencies Warned Against WhatsApp Discussions After Antitrust Raids
Apr 17, 2025 by
CPI
US Court Ruling Against Google Spurs Fresh Antitrust Tensions in Europe
Apr 17, 2025 by
CPI
AstraZeneca Accused of Stifling Biosimilar Competition for Rare Disease Drug
Apr 17, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Airline Industry
Apr 10, 2025 by
CPI
Boosting Competition in International Aviation
Apr 10, 2025 by
Jeffrey N. Shane
Reshaping Competition Policy for the U.S. Airline Industry
Apr 10, 2025 by
Diana L. Moss
Algorithmic Collusion in the Skies: The Role of AI in Shaping Airline Competition
Apr 10, 2025 by
Qi Ge, Myongjin Kim & Nicholas Rupp
Competition in U.S. Airline Markets: Major Developments and Economic Insights
Apr 10, 2025 by
Germán Bet